Concepedia

Publication | Open Access

Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations

35

Citations

15

References

2022

Year

Abstract

In contrast to what was observed in the context of chemotherapy-free ICI-based regimens, baseline BMI does not affect clinical outcomes from chemoimmunotherapy combinations in patients with advanced NSCLC.

References

YearCitations

Page 1